Estimates Revisions SOPHiA GENETICS SA Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
12:53:47 16/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.800 EUR | 0.00% |
|
-4.23% | +75.26% |
| 05/08 | SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026 | |
| 04/08 | Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
SOPHiA GENETICS SA(SOPH)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
- Consensus SOPHiA GENETICS SA
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
